Detalhe da pesquisa
1.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med
; 390(4): 326-337, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078508
2.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142374
3.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688395
4.
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Lancet
; 395(10232): 1278-1291, 2020 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305093
5.
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Br J Haematol
; 188(6): 918-923, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682002
6.
Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation.
Mol Cell Proteomics
; 17(4): 776-791, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367434
7.
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline.
Br J Haematol
; 204(1): 86-107, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957111
8.
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
Br J Haematol
; 185(4): 656-669, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768675
9.
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
Br J Haematol
; 201(2): 353-356, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793194
10.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
11.
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper.
Br J Haematol
; 196(4): 864-870, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607388
12.
Management of cardiovascular complications of bruton tyrosine kinase inhibitors.
Br J Haematol
; 196(1): 70-78, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498258
13.
Guideline for the treatment of chronic lymphocytic leukaemia.
Br J Haematol
; 197(5): 544-557, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313007
14.
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.
Haematologica
; 105(12): 2868-2871, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256390
15.
Importance of sequential analysis of TP53 variation in patients with Waldenström Macroglobulinaemia.
Br J Haematol
; 186(4): e73-e76, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968394
16.
Ventricular arrhythmias and sudden death in patients taking ibrutinib.
Blood
; 129(18): 2581-2584, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223277
17.
Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care.
Cancers (Basel)
; 16(5)2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473342
18.
Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline.
Br J Haematol
; 182(3): 344-359, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30009455
19.
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.
Blood Adv
; 7(12): 2794-2806, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696464
20.
Defining the prognosis of early stage chronic lymphocytic leukaemia patients.
Br J Haematol
; 156(4): 499-507, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22171799